Sponsor pipeline

Beam Therapeutics clinical trial pipeline

Get alerts when Beam Therapeutics's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
1
Phase 1/2
4
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT06389877 A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1… Alpha 1-Antitrypsin Deficiency Recruiting 2026-10-05
NCT06735755 A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in… Glycogen Storage Disease Type Ia Recruiting 2025-12-15
NCT05456880 BEACON: A Study Evaluating the Safety and Efficacy of BEAM-101 in Patients With Severe… Sickle Cell Disease Active, Not Recruiting 2025-12-16
NCT05885464 A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell… Lymphoblastic Lymphoma Active, Not Recruiting 2025-01-13
Phase 1
NCT07304791 This is a Phase 1, Randomized, Single-blind, Placebo-controlled Study to Assess the… Healthy Subjects Recruiting 2025-12-26
Not specified
NCT07373639 A Long-term Follow-up Study in Patients Who Received BEAM-101 Hemoglobinopathy Recruiting 2026-01-28

Disease areas by active trials

Sickle Cell Disease (2) · Acute Lymphoblastic Leukemia (ALL) (1) · Leukemia (1)

Get alerts when Beam Therapeutics's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free